Valneva SE (VALN) Non-Current Deferred Tax Liability (2020 - 2026)

Valneva SE's (VALN) quarterly Non-Current Deferred Tax Liability came in at $5.2 million in Q1 2026, up 19.33% year-on-year from $4.3 million in Q1 2025, and up 1.05% quarter-over-quarter from $5.1 million in Q4 2025.

Valneva SE (VALN) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends

Valneva SE has disclosed Non-Current Deferred Tax Liability across 7 years of filings, most recently posting $5.2 million for Q1 2026.

  • Non-Current Deferred Tax Liability for Q1 2026 came in at $5.2 million, up 19.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (up 19.33% YoY), and the FY2025 annual result was $5.1 million, up 15.4% from the prior year.
  • Non-Current Deferred Tax Liability came in at $5.2 million for Q1 2026 at Valneva SE, up from $5.1 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $6.8 million in Q4 2023 to a low of $708051.7 in Q4 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $4.0 million (2024), against an average of $3.4 million.
  • Peak annual rise in Non-Current Deferred Tax Liability reached 867.06% in 2023, while the deepest fall reached 49.9% in 2023.
  • Valneva SE's Non-Current Deferred Tax Liability stood at $708051.7 in 2022, then jumped by 867.06% to $6.8 million in 2023, then tumbled by 35.05% to $4.4 million in 2024, then increased by 15.4% to $5.1 million in 2025, then rose by 1.05% to $5.2 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $5.2 million (Q1 2026), $5.1 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.19 Mn
Mar 31, 2026 5.19 Mn
Dec 31, 2025 5.13 Mn
Dec 31, 2025 5.13 Mn
Sep 30, 2025 4.62 Mn
Sep 30, 2025 4.62 Mn
Jun 30, 2025 4.57 Mn
Jun 30, 2025 4.57 Mn
Mar 31, 2025 4.35 Mn
Mar 31, 2025 4.35 Mn
Dec 31, 2024 4.45 Mn
Dec 31, 2024 4.45 Mn
Sep 30, 2024 4.16 Mn
Sep 30, 2024 4.16 Mn
Jun 30, 2024 4.03 Mn
Jun 30, 2024 4.03 Mn
Mar 31, 2024 4.02 Mn
Mar 31, 2024 4.02 Mn
Dec 31, 2023 6.85 Mn
Dec 31, 2023 6.85 Mn